Archive for the ‘Biotech industry’ Category

Potential impact of Obama’s call for regulatory pathway for approving follow-on biologics

Friday, March 6th, 2009

Basic article on how the biotech industry might be affected by a regulatory pathway for approving follow-on biologics: here